Related Experiment Video
Updated: Apr 21, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
Postinduction Supportive Care of Pediatric Acute Myelocytic Leukemia: Should Patients be Kept in the Hospital?
Susumu Inoue1, Isra'a Khan2, Rao Mushtaq2
1Hurley Children's Hospital and Hurley Medical Center, One Hurley Plaza, Flint, MI 48503, USA ; Department of Pediatrics/Human Development, Michigan State University College of Human Medicine, One Hurley Plaza, Flint, MI 48503, USA.
Insights
Discharging children with acute myeloid leukemia (AML) while neutropenic after chemotherapy did not increase neutropenia-related deaths. This small study suggests hospital discharge is safe for these pediatric cancer patients.
Area of Science:
- Pediatric Oncology
- Hematology
Background:
- Children with acute myeloid leukemia (AML) experience profound neutropenia during remission induction chemotherapy.
- The safety of hospital discharge during severe neutropenia in pediatric AML patients is not well-established.
Purpose of the Study:
- To evaluate whether discharging pediatric AML patients during profound neutropenia impacts survival.
Main Methods:
- Retrospective review of AML patients treated at the institution from 1989 to 2011.
- Analysis of outcomes for 13 patients electively discharged during severe neutropenia post-induction chemotherapy.
Main Results:
- Four patients died due to relapse or transplant complications, not neutropenia-related issues.
- Eight patients achieved long-term survival.
- Elective discharge during profound neutropenia did not appear to negatively affect survival in this cohort.
Conclusions:
- Hospital discharge of pediatric AML patients with profound neutropenia, when clinically appropriate, may be a safe practice.
- Further research with larger cohorts is warranted to confirm these findings.
Abstract:
Children with AML become profoundly neutropenic while they undergo remission induction chemotherapy. It is unknown whether these children should be kept in the hospital while they are severely neutropenic to prevent life-threatening complications associated with neutropenia and reduce fatality. We at our institution routinely discharge patients after completing remission induction chemotherapy in the presence of profound neutropenia, unless it is clinically contraindicated. We reviewed all AML patients who were consecutively treated at our hospital from 1989 to 2011. Thirteen patients were electively discharged after completion of induction I chemotherapy. Of the 13, 4 died due to relapse or complications of stem cell transplants (not due to neutropenia related complications). Another eight are long term survivors. In this very small series, discharge from the hospital even though patients were severely neutropenic did not adversely affect the survival.
Related Concept Videos
Acute Kidney Injury VI: Nursing Management
Differentiation of Common Myeloid Progenitor Cells
Acute Kidney Injury I: Introduction
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...

